Pharma Mar, S.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 19.01 million compared to EUR 16.37 million a year ago. Revenue was EUR 37.97 million compared to EUR 33.98 million a year ago.

Net income was EUR 2.3 million compared to EUR 1.41 million a year ago.